Dr Lalchandani Labs Ltd - Stock Valuation and Financial Performance

BSE: 541299 | NSE: | Hospital & Healthcare Services | Small Cap

Dr Lalchandani Labs Share Price

15.71 -0.75 -4.56%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Dr Lalchandani Labs

M-Cap below 100cr DeciZen not available

Dr Lalchandani Labs stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
6.8 Cr.
52-wk low:
15.7
52-wk high:
35

Is Dr Lalchandani Labs Ltd an attractive stock to invest in?

1. Is Dr Lalchandani Labs Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dr Lalchandani Labs Ltd is a below average quality company.

2. Is Dr Lalchandani Labs Ltd undervalued or overvalued?

The key valuation ratios of Dr Lalchandani Labs Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Dr Lalchandani Labs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dr Lalchandani Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Dr Lalchandani Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dr Lalchandani Labs Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0%0%0%0%7.2%8.9%6.3%10.6%9.3%-5.6%-
Value Creation
Index
NANANANA-0.5-0.4-0.6-0.3-0.3-1.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00002.85.36.19.811.355
Sales YoY Gr.-NANANANA88.5%16%60.3%15.3%-55.3%-
Adj EPS 00000.91.21.12.32.2-3.6-3.6
YoY Gr.-NANANANA38.2%-11.4%113.8%-7.7%-267.9%-
BVPS (₹) 00001117.518.921.523.920.620.6
Adj Net
Profit
00000.30.50.510.9-1.6-2
Cash Flow from Ops. 00000.6-0.5-0.11.220-
Debt/CF from Ops. 00003.2-2-18.13.42.65337.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA12.6%-6.2%-55.3%
Adj EPS NA-232.3%-249.1%-267.9%
BVPSNA13.3%2.9%-14%
Share Price - -4.2% 12.6% -44.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
00007.99.45.711.29.3-16.1-17.5
Op. Profit
Mgn %
000022.122.820.82321.91.8NAN
Net Profit
Mgn %
00009.410.17.810.38.3-31-30.9
Debt to
Equity
00000.60.10.20.40.50.7-
Working Cap
Days
000002452922282446320
Cash Conv.
Cycle
00000348696993120

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.72

Return on Equity is Poor

Sales growth has been subdued in last 3 years -6.16%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Dr Lalchandani Labs Ltd.

Standalone Consolidated
TTM EPS (₹) -3.6 -
TTM Sales (₹ Cr.) 5 -
BVPS (₹.) 20.6 -
Reserves (₹ Cr.) 5 -
P/BV 0.76 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 15.68 / 35.00
All Time Low / High (₹) 6.75 / 52.50
Market Cap (₹ Cr.) 6.8
Equity (₹ Cr.) 4.3
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Dr Lalchandani Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dr Lalchandani Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales2.795.266.109.7811.285.04
Operating Expenses 2.174.064.847.538.814.95
Manufacturing Costs0.540.791.031.321.230.49
Material Costs0.630.611.153.612.981.21
Employee Cost 0.300.670.570.421.111.11
Other Costs 0.701.992.092.203.502.13
Operating Profit 0.621.201.272.252.470.09
Operating Profit Margin (%) 22.1%22.8%20.8%23.0%21.9%1.8%
Other Income 0.030.010000
Interest 0.160.140.180.350.600.99
Depreciation 0.130.350.420.520.590.66
Exceptional Items 000000
Profit Before Tax 0.350.720.661.381.29-1.56
Tax 0.090.190.190.370.350
Profit After Tax 0.260.530.471.010.93-1.56
PAT Margin (%) 9.4%10.1%7.8%10.3%8.3%-31.0%
Adjusted EPS (₹)0.91.21.12.32.2-3.6
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 3.338.078.549.5510.498.92
Share Capital 2.934.334.334.334.334.33
Reserves 0.403.734.215.226.154.59
Minority Interest000000
Debt1.340.651.513.404.044.68
Long Term Debt1.290.601.462.642.623.32
Short Term Debt0.050.050.050.761.421.37
Trade Payables0.690.681.120.961.431.34
Others Liabilities 0.840.740.761.292.172.77
Total Liabilities 6.2110.1411.9315.2018.1217.72

Fixed Assets

Gross Block2.193.764.356.657.748.05
Accumulated Depreciation0.130.480.881.401.992.65
Net Fixed Assets2.063.283.475.245.755.39
CWIP 000000
Investments 0.240.240.240.240.240.24
Inventories0.270.390.500.681.561.52
Trade Receivables1.141.833.333.984.224.97
Cash Equivalents 0.912.022.252.893.533.10
Others Assets1.592.382.142.162.832.50
Total Assets 6.2110.1411.9315.2018.1217.72

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.58-0.45-0.101.192.010
PBT 0.350.720.661.381.29-1.56
Adjustment 0.290.350.420.691.071.54
Changes in Working Capital -0.06-1.45-1.02-0.57-0.020.03
Tax Paid 0-0.07-0.16-0.31-0.330
Cash Flow From Investing Activity -1.29-1.95-0.53-2.26-1.53-0.20
Capex -1.30-1.57-0.61-2.29-1.10-0.30
Net Investments 000.11000
Others 0.01-0.37-0.030.03-0.430.11
Cash Flow From Financing Activity 1.573.510.851.710.16-0.23
Net Proceeds from Shares 2.144.200000
Net Proceeds from Borrowing -0.33-0.690.851.18-0.020.70
Interest Paid -0.1400-0.18-0.48-0.88
Dividend Paid 000000
Others -0.10000.710.67-0.06
Net Cash Flow 0.851.120.230.640.64-0.43
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)8.119.856.0111.569.49-16.23
ROCE (%)10.0612.579.1714.8813.07-3.69
Asset Turnover Ratio0.450.640.550.720.680.28
PAT to CFO Conversion(x)2.23-0.85-0.211.182.16N/A
Working Capital Days
Receivable Days149103154136133332
Inventory Days3623272236111
Payable Days400412287106147416

Dr Lalchandani Labs Ltd Stock News

Dr Lalchandani Labs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dr Lalchandani Labs on 28-Mar-2024 16:01 is ₹15.71.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Dr Lalchandani Labs stood at ₹6.81.
The latest P/E ratio of Dr Lalchandani Labs as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Dr Lalchandani Labs as of 28-Mar-2024 16:01 is 0.76.
The 52-week high of Dr Lalchandani Labs is ₹35.00 and the 52-week low is ₹15.68.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dr Lalchandani Labs is ₹5.04 ( Cr.) .

About Dr Lalchandani Labs Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.